secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zymeworks Inc. (ZYME)
CIK:        0001937653
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001193125-23-178592
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zymeworks appoints Carlos Campoy to board; director Natalie Sacks resigns effective June 30, 2023
--------------------------------------------------------------------------------

- Carlos Campoy appointed as Class I director effective June 30, 2023, term expiring at 2025 AGM.
- Campoy receives initial grant of 50,000 common shares as part of standard non-employee director compensation.
- Natalie Sacks resigned effective June 30, 2023; resignation not due to any disagreement with the company.
- Campoy joins audit and nominating/corporate governance committees; Kelvin Neu named chair of R&D committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937653/000119312523178592/0001193125-23-178592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937653/000119312523178592/d307320d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-178592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer